FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:716-727 February 14, 2008 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Acute lower respiratory tract infections are a persistent and pervasive public health problem. They cause a greater burden of disease worldwide than human immunodeficiency virus infection, malaria, cancer, or heart attacks.¹ In the United States, they cause more disease and death than any other infection, and there has been little change in mortality due to respiratory tract infection for more than five decades.^1,2 The outcome of an acute lower respiratory tract infection depends on the virulence of the organism and the inflammatory response in the lung. When small numbers of low-virulence microbes are deposited in the lungs, an effective defense . . . [Full Text of this Article]

Inflammation and Innate Immunity

Generation of Acute Inflammation in Infected Lungs

Molecules That Detect Microbes

Sentinel Cells in the Lungs

Effectors of Innate Immunity

Inflammation and Acute Lung Injury

Regulation of Acute Inflammation in Infected Lungs

Responses of Microbes to Inflammation

Genetic Variation in Inflammatory Pathways

Conclusions

Source Information

From the Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston.

Address reprint requests to Dr. Mizgerd at Molecular and Integrative Physiological Sciences, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115, or at jmizgerd@hsph.harvard.edu.

Related Letters:

Acute Lower Respiratory Tract Infection
Eisenhut M., Mizgerd J. P.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:2413-2414, May 29, 2008. Correspondence

This article has been cited by other articles:

• Cai, S., Batra, S., Shen, L., Wakamatsu, N., Jeyaseelan, S. (2009). Both TRIF- and MyD88-Dependent Signaling Contribute to Host Defense against Pulmonary Klebsiella Infection. J. Immunol. 183: 6629-6638 [Abstract] [Full Text]  
• Marti-Lliteras, P., Regueiro, V., Morey, P., Hood, D. W., Saus, C., Sauleda, J., Agusti, A. G. N., Bengoechea, J. A., Garmendia, J. (2009). Nontypeable Haemophilus influenzae Clearance by Alveolar Macrophages Is Impaired by Exposure to Cigarette Smoke. Infect. Immun. 77: 4232-4242 [Abstract] [Full Text]  
• Sharma, J., Li, Q., Mishra, B. B., Georges, M. J., Teale, J. M. (2009). Vaccination with an Attenuated Strain of Francisella novicida Prevents T-Cell Depletion and Protects Mice Infected with the Wild-Type Strain from Severe Sepsis. Infect. Immun. 77: 4314-4326 [Abstract] [Full Text]  
• Kantrow, S. P., Shen, Z., Jagneaux, T., Zhang, P., Nelson, S. (2009). Neutrophil-mediated lung permeability and host defense proteins. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L738-L745 [Abstract] [Full Text]  
• Bianchi, M., Hakkim, A., Brinkmann, V., Siler, U., Seger, R. A., Zychlinsky, A., Reichenbach, J. (2009). Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114: 2619-2622 [Abstract] [Full Text]  
• Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., Regez, K., Schoenenberger, R., Henzen, C., Bregenzer, T., Hoess, C., Krause, M., Bucher, H. C., Zimmerli, W., Mueller, B., for the ProHOSP Study Group, (2009). Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections: The ProHOSP Randomized Controlled Trial. JAMA 302: 1059-1066 [Abstract] [Full Text]  
• Yealy, D. M., Fine, M. J. (2009). Measurement of Serum Procalcitonin: A Step Closer to Tailored Care for Respiratory Infections?. JAMA 302: 1115-1116 [Full Text]  
• Quinton, L. J., Jones, M. R., Robson, B. E., Mizgerd, J. P. (2009). Mechanisms of the Hepatic Acute-Phase Response during Bacterial Pneumonia. Infect. Immun. 77: 2417-2426 [Abstract] [Full Text]  
• Cai, S., Zemans, R. L., Young, S. K., Worthen, G. S., Jeyaseelan, S. (2009). Myeloid Differentiation Protein-2-Dependent and -Independent Neutrophil Accumulation during Escherichia coli Pneumonia. Am. J. Respir. Cell Mol. Bio. 40: 701-709 [Abstract] [Full Text]  
• Li, Y., Jia, Y., Pichavant, M., Loison, F., Sarraj, B., Kasorn, A., You, J., Robson, B. E., Umetsu, D. T., Mizgerd, J. P., Ye, K., Luo, H. R. (2009). Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia. Blood 113: 4930-4941 [Abstract] [Full Text]  
• van Zoelen, M. A. D., Schouten, M., de Vos, A. F., Florquin, S., Meijers, J. C. M., Nawroth, P. P., Bierhaus, A., van der Poll, T. (2009). The Receptor for Advanced Glycation End Products Impairs Host Defense in Pneumococcal Pneumonia. J. Immunol. 182: 4349-4356 [Abstract] [Full Text]  
• Craig, A., Mai, J., Cai, S., Jeyaseelan, S. (2009). Neutrophil Recruitment to the Lungs during Bacterial Pneumonia. Infect. Immun. 77: 568-575 [Full Text]  
• Hirche, T. O., Benabid, R., Deslee, G., Gangloff, S., Achilefu, S., Guenounou, M., Lebargy, F., Hancock, R. E., Belaaouaj, A. (2008). Neutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa. J. Immunol. 181: 4945-4954 [Abstract] [Full Text]  
• Serezani, C. H., Ballinger, M. N., Aronoff, D. M., Peters-Golden, M. (2008). Cyclic AMP: Master Regulator of Innate Immune Cell Function. Am. J. Respir. Cell Mol. Bio. 39: 127-132 [Abstract] [Full Text]  
• Annane, D., Umberto Meduri, G., Marik, P. (2008). Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!. Eur Respir J 31: 1150-1152 [Full Text]  
• Eisenhut, M., Mizgerd, J. P. (2008). Acute Lower Respiratory Tract Infection. NEJM 358: 2413-2414 [Full Text]